Results - Announcements
Aarti Pharmalabs Ltd share price surged by 9.12% to Rs 1009.0 after the company's net profit slipped by 6.13% to Rs 71.47 crore, while revenue from operations gained 13.93% to Rs 610.45 crore in Q2FY27 over Q2FY26.
The market capitalization of Pharmaceuticals industry group stocks on BSE stood at Rs 27.83 lakh crore, rising 6.40%. It has inched up 2.89% over last one week and ticked higher by 6.37% in last one month while the market capitalization of Aarti Pharmalabs Ltd has improved by 8.62% and 18.41% in the same period respectively.
Profit before tax (PBT) of Aarti Pharmalabs Ltd stood at Rs 94.99 crore in Q2 FY27, rallying 145.52% year-on-year, and slipping 6.01% quarter-on-quarter. EBITDA came in at Rs 135 crore, expanding by 80.38% YoY and declining 0.72% sequentially.
Total expenses rose by 17.71% to Rs 505.82 crore in Q2FY27 over Q2FY26. During the quarter, cost of materials consumed stood at Rs 334.88 crore, jumping 32.96% YoY, while employee benefits expense was at Rs 54.55 crore, rising by 8.41% YoY.
For FY26, revenue from operations declined by 13.98% to Rs 1819.44 crore, while net profit plunged by 35.86% to Rs 174.71 crore, compared to previous FY. EBITDA witnessed a strong improvement of 47069% to Rs 359.46 crore, and PBT tumbled by 35.42% to Rs 232.92 crore compared to previous FY.
The company's consolidated net cash flow from operating activities stood at Rs 261.93 crore in FY26, as against Rs 330.14 crore in FY25.
Aarti Pharmalabs Ltd jumped 32.85% in last one year, significantly outperforming the benchmark BSE Sensex which has softened by 3.03% during the same period.
